Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?

Research output: Contribution to journalLetter

Details

Authors
Organisations
External organisations
  • Skåne University Hospital
  • Academic Medical Center of University of Amsterdam (AMC)
  • University of Copenhagen
  • Växjö Central Hospital
  • Copenhagen University Hospital
  • Örebro University Hospital
  • University of Amsterdam
  • Radboud University Medical Center
  • Wroclaw Research Centre EIT+
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Neurology

Keywords

  • Adult, Ataxia, Brown-Vialetto-Van Laere syndrome-2, BVVLS2, Pharmacokinetics, Recessive, Riboflavin transporter deficiency, SLC52A2, Treatment
Original languageEnglish
Pages (from-to)245-247
Number of pages3
JournalParkinsonism & Related Disorders
Volume61
Publication statusPublished - 2019
Publication categoryResearch
Peer-reviewedYes